PCRX vs PRAX
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 08, 2026
PCRX
PRAX
Investment Advisor Scores
PRAX
AI Analyst Insights
Detailed Metrics Comparison
| Metric | PCRX | PRAX | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 6.25 | 0 | Tie |
| PEG Ratio | 11.2121 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 6.2% | 1349.1% | PRAX |
| Earnings Growth | -30.0% | 0.0% | PRAX |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 40.9/100 | 38.8/100 | PCRX |
| Profit Margin | 2.0% | 0.0% | PCRX |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | AVOID NEW MONEY | PCRX |
Relative Price Performance (Last 90 Days)
Current Technical Phase
PCRX
MarkupPrice above SMA50, rising 50-day trend (8.8% over 20 days), RSI 84
PRAX
MarkdownPrice below a falling SMA50 (slope -6.9%), weak momentum, RSI 40
Fundamentals Snapshot
| Metric | PCRX | PRAX |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 10.5 | -27.3 |
| Trailing P/E | 103.8 | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.1% | 13.5% |
| Gross Margin | 0.8% | -39.0% |
| Operating Margin | 0.1% | 0.0% |
| EPS | 0.35 | -12.95 |
| Dividend Yield | — | — |